Vertex Pharmaceuticals
VRTX
VRTX
582 hedge funds and large institutions have $30.4B invested in Vertex Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 219 increasing their positions, 183 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 522 → 582 (+60)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
0.2% less ownership
Funds ownership: 95% → 94.8% (-0.2%)
Holders
582
Holding in Top 10
8
Calls
$416M
Puts
$169M
Top Buyers
| 1 | +$437M | |
| 2 | +$193M | |
| 3 | +$134M | |
| 4 |
Morgan Stanley
New York
|
+$128M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$72.5M |
Top Sellers
| 1 | -$299M | |
| 2 | -$228M | |
| 3 | -$221M | |
| 4 |
JP Morgan Chase
New York
|
-$118M |
| 5 |
Goldman Sachs
New York
|
-$105M |